Autologous umbilical cord blood (UCB) infusion registaration for cerebral palsy or cerebral damage in Kochi

Autologous umbilical cord blood (UCB) infusion registaration for cerebral palsy or cerebral damage in Kochi - CBReCK

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024852

Enrollment

Registered

2017-01-01

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral palsy

Interventions

autologous umbilical cord blood (UCB) Single venous injection of UCB with 100ml of saline solution over 1 hr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases meet two requirements as follows: 1. Cases under 7 year-old-age 1)Cerebral palsy, or 2)Moderate or severe type of hypoxic ishchemic encephalopathy, or 3)Periventricular leukomalacia 2.Cases with stored autologous UCB Cord blood mononuclear cell counts is over 1.2E+06 cells and its viability is over 60 percentage.

Exclusion criteria

Exclusion criteria: cases meet one of 7 requiremente as follows: 1)Gene anomaly 2)Malignancy 3)Mother with positive for B and C type hepatitis, or HIV, or HTLV-1, or sphilis 4)Steroid allergy 5)UCB with positive for bacterias 6)Cases decided to be inappropriate by doctors 7)Cases without consent

Design outcomes

Primary

Measure	Time frame
Evaluation of safety	—

Secondary

Measure	Time frame
Evaluation of beneficial change for developemental and motor disorders	—

Countries

Japan

Contacts

Public ContactMikiya Fujieda

Kochi Medical School Hospital Department of Pediatrics

fujiedam@kochi-u.ac.jp088-880-2355

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026